한국인 나이관련황반변성 환자의 우울 및 불안에 대한 조사 및 그 영향에 대한 고찰
Depression and Anxiety in Korean Patients with Age-Related Macular Degeneration
1
조회
0
다운로드
5
인용
0
참고문헌
키워드
초록
목적: 한국인 삼출성 나이관련황반변성 환자의 우울 및 불안정도를 알아보고 기분상태가 환자의 치료 만족도 및 순응도에 미치는 영향을 알아보고자 하였다. 대상과 방법: 2010년 6월부터 8월까지 나이관련황반변성 환자 44명을 대상군으로, 백내장 수술을 위해 일일 입원한 환자 33명을 대조군으로 선정하였다. 한국판 Beck 우울척도와 불안척도를 사용하여 우울 및 불안정도를 측정하였고 대상군 44명을 1년 뒤 추적 관찰하여 기분상태가 환자의 치료 만족도 및 순응도에 미치는 영향을 평가하였다. 결과: 대상군의 한국판 Beck 우울척도 및 불안척도는 13.9 ± 7.6, 8.6 ± 7.2로 대조군의 10.8 ± 8.8, 6.8 ± 6.4에 비해 높았고 이점수는 주사 후 환자의 주관적 만족도와 강한 음의 상관관계를 보였다. 대상군 44명 중 14명(31.8%)의 경과관찰이 중단되었고 유지된환자에 비해 우울 및 불안척도 점수가 높았다. 결론: 나이관련황반변성 환자들의 우울 및 불안의 기분상태는 환자의 치료 만족도 및 순응도에 영향을 주었다. 이에 대한 관심 및관리는 환자의 시각적 기능을 높이고 삶의 질을 향상시키는 데에도 영향을 줄 수 있다.
Abstract
Purpose: To examine the degree of depression and anxiety in Korean patients with age-related macular degeneration (AMD) and to evaluate the influence of mood disturbance on patient’s treatment satisfaction and compliance. Methods: Forty-four patients with AMD and thirty-three controls comprised the study populations. Patients and controls rated themselves on the Korean Beck Depression Inventory (BDI) and Beck Anxiety Inventory (BAI). The effect of mood disturbance on the patient’s satisfaction and compliance was evaluated. Results: The depression and anxiety scores were significantly higher in patients with AMD. The mood disturbance was negatively correlated with the patient’s satisfaction and compliance. 14 patients (31.8%) were lost to follow-up 1 year later. The depression and anxiety scores of these patients were higher than those of remaining thirty patients. Conclusions: Depression and anxiety of patients with AMD affect on patient’s satisfaction and compliance. So recognition and management of mood disturbance may help improving visual function and maintaining quality of life in patients.
참고문헌 (30)
- Congdon N, "Causes and prevalence of visual impairment among adults in the United States", Arch Ophthalmol, 122, pp.477~485 (2004)
- Friedman DS, "Prevalence of age-related macular degeneration in the United States", Arch Ophthalmol, 122, pp.564~572 (2004)
- Rein DB, "Forecasting age-related macular degeneration through the year 2050: the potential impact of new treatments", Arch Ophthalmol, 127, pp.533~540 (2009)
- 염동주, "건강 검진을 위해 내원한 50세 이상 한국 성인에서 유리체망막 질환의 유병률", 대한안과학회지, 50(11), pp.1645~1651 (2009), 대한안과학회
- 박규형, "국내의 나이관련황반변성에 대한 기초역학조사", 대한안과학회지, 51(4), pp.516~523 (2010), 대한안과학회
- Slakter JS, "Quality of life in patients with age-related macular degeneration: impact of the condition and benefits of treatment", Surv Ophthalmol, 50, pp.263~273 (2005)
- Casten RJ, "Age-related macular degeneration and depression: a review of recent research", Curr Opin Ophthalmol, 15, pp.181~183 (2004)
- Augustin A, "Anxiety and depression prevalence rates in age-related macular degeneration", Invest Ophthalmol Vis Sci, 48, pp.1498~1503 (2007)
- Rovner BW, "Psychological and cognitive determinants of vision function in age-related macular degeneration", Arch Ophthalmol, 129, pp.885~890 (2011)
- Rees G, "Vision-specific distress and depressive symptoms in people with vision impairment", Invest Ophthalmol Vis Sci, 51, pp.2891~2896 (2010)
- Mathew RS, "Depressive symptoms and quality of life in people with age-related macular degeneration", Ophthalmic Physiol Opt, 31, pp.375~380 (2011)
- Casten R, "Depression in age-related macular degeneration", J Vis Impair Blind, 102, pp.591~599 (2008)
- Casten R, "Depression despite anti-vascular endothelial growth factor treatment of age-related macular degeneration", Arch Ophthalmol, 128, pp.506~508 (2010)
- Nielsen AC 3rd, "Prevalence by self-report questionnaire and recognition by nonpsychiatric physicians", Arch Gen Psychiatry, 37, pp.999~1004 (1980)
- Rhee MK, "A standardization study of Beck depression inventory I; Korean version (K-BDI): reliability and factor analysis", Korean J Psychopathol, 4, pp.77~95 (1995)
- Seo SK, "Relationship between self-discrepancy and depression or anxiety with consideration of self-focused attention, actual self-concept, and self-guides preference", 석사, pp.1996
- Chang TS, "Improved vision-related function after ranibizumab treatment of neovascular age-related macular degeneration: results of a randomized clinical trial", Arch Ophthalmol, 125, pp.1460~1469 (2007)
- Owsley C, "Depression and the 25-item National Eye Institute Visual Function Questionnaire in older adults", Ophthalmology, 111, pp.2259~2264 (2004)
- Miskala PH, "Relative contributions of reduced vision and general health to NEI-VFQ scores in patients with neovascular age-related macular degeneration", Arch Ophthalmol, 122, pp.758~766 (2004)
- Cubo E, "Cognitive and motor function in patients with Parkinson’s disease with and without depression", Clin Neuropharmacol, 23, pp.331~334 (2000)
- Brody BL, "Depression, visual acuity, comorbidity, and disability associated with age-related macular degeneration", Ophthalmology, 108, pp.1893~1900 (2001)
- Paz SH, "Relationship between self-reported depression and self-reported visual function in Latinos", Arch Ophthalmol, 121, pp.1021~1027 (2003)
- Rovner BW, "Effect of depression on vision function in age-related macular degeneration", Arch Ophthalmol, 120, pp.1041~1044 (2002)
- Watson M, "Influence of psychological response on survival in breast cancer: a population-based cohort study", Lancet, 354, pp.1331~1336 (1999)
- Frasure-Smith N, "Depression and 18-month prognosis after myocardial infarction", Circulation, 91, pp.999~1005 (1995)
- Barefoot JC, "Depressive symptoms and survival of patients with coronary artery disease", Psychosom Med, 62, pp.790~795 (2000)
- Carney C., "Diabetes mellitus and major depressive disorder: an overview of prevalence, complications, and treatment", Depress Anxiety, 7, pp.149~157 (1998)
- 전병희, "당뇨병 환자에서 우울증상 및 불안증상과 혈당조절과의 연관성", 정신신체의학, 16(2), pp.95~102 (2008), 한국정신신체의학회
- Brody BL, "Self-management of age-related macular degeneration at the 6-month follow-up: a randomized controlled trial", Arch Ophthalmol, 123, pp.46~53 (2005)
- Kandula S, "Patients’ knowledge and perspectives on wet age-related macular degeneration and its treatment", Clin Ophthalmol, 4, pp.375~381 (2010)